The Lancet

The Lancet


Welcome to The Lancet on Twitter. Keep in touch with The Lancet, one of the world's leading general medical journals, published weekly since 1823.

590759 followers  •  284 follow  •  London  •   http://www.thelancet.com

Top 5 risk factors for death for females in 2019 #GBDStudy  @IHME_UW  1. High blood pressure 2. Dietary risks 3. High fasting plasma glucose 4. Air pollution 5. High body-mass index Read#openaccess 

tweet picture

Photographs have a unique power to illuminate our world 📸 We want to see compelling, thought-provoking photographs that frame the important health stories of our times. Our annual photography competition Highlights is open for submissions until Nov 16

tweet picture

NEW—"We need action from individuals, organisations, governments & donors to enable & sustain the generation & use of evidence synthesis in LMICs if we are to tackle #COVID19  globally" Comment from R Stewart, et al, for the LMIC members of COVID-END

From peer review, through our in-house editing process, production, to publication and beyond, the entire Lancet team brings a wealth of expertise in scholarly publishing. During #OAWeek , learn about the journey of a paper at @TheLancet  journals 20 #OAWeek20 

NEW—Use of adenovirus type-5 vectored vaccines: a cautionary tale "This important safety consideration should be thoroughly evaluated before further development of Ad5 vaccines for SARS-CoV-2" Correspondence from Susan Buchbinder et al

NEW—The Brazilian Government's mistakes in responding to the #COVID19  pandemic Correspondence from Sabrina Ferigato, Michelle Fernandez, Melania Amorim, Ilana Ambrogi, Luísa M M Fernandes & Rafaela Pacheco

NEW—In the 2020 US election, we can choose a just future "The choice is stark and the stakes are high" Comment from Rhea W Boyd, Nancy Krieger & Camara Phyllis Jones#Election2020 

tweet picture

Health depends on more than health systems: has the gaze of #globalhealth  been too narrow? Editorial on #GBDStudy  and #COVID19 

tweet picture

Editor's Pick on The Lancet's #COVID19  Resource Centre—An Article in @LancetLongevity  maps the physical access to health care for older adults in sub-Saharan Africa and discusses the implications for COVID-19 response

tweet picture

Loading
Loading

Today, three of the authors have retracted "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis" Read the Retraction notice and statement from The Lancet

tweet picture

NEW—UK’s #COVID19  vaccine is safe and induces an immune reaction, according to preliminary results

tweet picture

NEW Research—No evidence of benefit for #chloroquine  and #hydroxychloroquine  in #COVID19  patients, urgent randomised trials are needed: finding from a large observational study of nearly 15,000 patients with #COVID19  & 81,000 controls Thread (1/4)

tweet picture

NEW Correspondence—80+ researchers warn that a so-called #herdimmunity  approach to managing #COVID19  is “a dangerous fallacy unsupported by the scientific evidence” #WCPH2020 

tweet picture

NEW—Most comprehensive study to date provides evidence on optimal physical distancing, face masks, and eye protection to prevent spread of #COVID19 : a systematic review and meta-analysis of 172 observational studies

tweet picture

Just published: Two new studies on the novel coronavirus. All Lancet #coronavirus  content is fully and freely available at our 2019-nCoV Resource Centre

tweet picture

We have published an Expression of Concern on the paper by Mehra et al on hydroxychloroquine and chloroquine published on May 22, 2020

tweet picture

Loading
Loading